MedTrace Logo

Vascular No-React Graft Against Infection

NCT04031001 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 43

Last updated 2023-12-21

No results posted yet for this study

Summary

This study seeks to demonstrate the effectiveness and safety of the Non-valved Conduit for CE marking on the basis of infection. The rationale for infection resistance with the conduit is that BioIntegral Surgical No-React® treated products have a well-documented history of infection resistance in hybrid vascular settings.

Conditions

  • Vascular Infections

Interventions

DEVICE

No-React Non-valved Conduit

Operative replacement of infected graft or implantation in infected area.

Sponsors & Collaborators

  • Catharina Ziekenhuis Eindhoven

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-22
Primary Completion
2021-02-06
Completion
2021-07-13

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04031001 on ClinicalTrials.gov